Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
PFO-sluiting verkleint risico nieuwe beroerte bij jonge en fitte patiënt
jun 2020 | Neuro-vasculair